Berndt Modig is the founder of Pharvaris. Pharvaris has raised $353M in total funding. Latest round: IPO. Based in Leiden, Netherlands.
Berndt Modig is the Co-founder and Chief Executive Officer of Pharvaris, a clinical-stage biopharma company focused on developing oral treatments for hereditary angioedema (HAE). He founded Pharvaris in 2015 and has led the company through multiple funding rounds and its IPO on NASDAQ in February 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library